fda tirzepatide ruling TIRZEPATIDE: VERDICT, 📝Messages conveyed here are of my own understandings, views, and perceptions of the latest ruling. 📌 All points are subject to change based on FDA rulings and compliance with What Changed? The FDA's Clarification

Katherine McDaniel, MD, FACOG, is a reproductive endocrinology and infertility specialist in Pasadena, California

Despite these benefits, these trials assessed cardiovascular clinical endpoints rather than myocardial structure or ECM collagen deposition, and thus do not establish a fibrosis-mediated mechanism

However, optimal performance was achieved at 100 mg/mL, where drug loading was about 9% and encapsulation efficiency exceeded 90%

Cardiovascular risk reduction with once-weekly semaglutide in subjects with type 2 diabetes: a post hoc analysis of gender, age, and baseline CV risk profile in the SUSTAIN 6 trial